Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

App-Based diet plan could ease IBS symptoms for millions

NCT ID NCT07543354

Symptom relief Sponsor: Taipei Veterans General Hospital, Taiwan Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a mobile app can help doctors and dietitians create a personalized low-FODMAP diet for people with Irritable Bowel Syndrome (IBS). About 200 adults with IBS will either use the app or receive a diet booklet. The goal is to reduce stomach pain, bloating, and other symptoms, and to understand how the diet affects the gut-brain connection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Jun 2029

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants aged between 20 and 65 years. * Diagnosed with Irritable Bowel Syndrome (IBS) * Overall IBS symptoms remain unresolved or active at the time of enrollment. Exclusion Criteria: * Inability to understand the study procedures or provide written informed consent. * Currently pregnant. * History of Inflammatory Bowel Disease (IBD). * Active infection within the past 90 days. * History of thyroid disease. * Major psychiatric disorders, including patients with significant anxiety or depression currently requiring treatment with anti-anxiety or anti-depressant medications. * History of epilepsy. * History of stroke, cerebral hemorrhage, or other central nervous system diseases. * Significant renal, hepatic, or major cardiovascular diseases. * Malignant diseases (cancer). * Type 2 diabetes. * Other chronic pain conditions. * History of abdominal surgery (excluding cholecystectomy or appendectomy) or any history of brain surgery. * Appendectomy or cholecystectomy performed within the past year. * Currently participating in other clinical trials. * Use of antibiotics or analgesics within 90 days prior to enrollment. * Newly initiated use of probiotics or prebiotics within 90 days prior to enrollment. * Current use of antipsychotic medications, antidiarrheal agents, probiotics, or analgesics.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IBS - irritable bowel syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

irritable bowel syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

IBS - irritable bowel syndrome

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Taipei Veterans General Hospital

    Taipei, 112, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.